筛选出 7 条数据

    品牌 产品 货期 价格 货号 规格 /
    内分泌与激素382-44-5

    CAS号:382-44-5

    品名:4-雄烯-11β-醇-3,17-二酮11β-hydroxyandrost-4-ene-3,17-dione

    中文别名:11β-羟基雄甾-4-烯-3,17-二酮;4-Androsten-11β-ol-3,17-dione;11BETA-羟基-4-雄甾烯-3,17-二酮;11β-Hydroxy-4-androstene-3,17-dione;

    英文别名:(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione;U2826;Androst-4-ene-3,17-dione,11-hydroxy-,(11β)-;4-Androsten-11beta-ol-3,17-dione;11beta-hydroxyandrost-4-ene-3,17-dione;11beta-Hydroxyandrostenedione;Androst-4-ene-3,17-dione-11beta-ol;11beta-Hydroxyandrost-4-ene-3,17-dione;11b-Hydroxyandrost-4-ene-3,17-dione;

    分子式:C19H26O3

    分子量:302.408

    精确质量:302.188

    Psa:54.37

    UNII号:41G81C896T

    密度:1.19g/cm3

    沸点:475.3ºC at 760mmHg

    闪点:255.4ºC

    折射率:1.569

    简介:4-Androsten-11β-ol-3,17-dioneisasteroidhormone.AnanalogofAndrostenedione.

     382-44-5 详细信息

    内分泌与激素

    CAS号:382-44-5

    品名:4-雄烯-11β-醇-3,17-二酮11β-hydroxyandrost-4-ene-3,17-dione

    中文别名:11β-羟基雄甾-4-烯-3,17-二酮;4-Androsten-11β-ol-3,17-dione;11BETA-羟基-4-雄甾烯-3,17-二酮;11β-Hydroxy-4-androstene-3,17-dione;

    英文别名:(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione;U2826;Androst-4-ene-3,17-dione,11-hydroxy-,(11β)-;4-Androsten-11beta-ol-3,17-dione;11beta-hydroxyandrost-4-ene-3,17-dione;11beta-Hydroxyandrostenedione;Androst-4-ene-3,17-dione-11beta-ol;11beta-Hydroxyandrost-4-ene-3,17-dione;11b-Hydroxyandrost-4-ene-3,17-dione;

    分子式:C19H26O3

    分子量:302.408

    精确质量:302.188

    Psa:54.37

    UNII号:41G81C896T

    密度:1.19g/cm3

    沸点:475.3ºC at 760mmHg

    闪点:255.4ºC

    折射率:1.569

    简介:4-Androsten-11β-ol-3,17-dioneisasteroidhormone.AnanalogofAndrostenedione.

    展开

    内分泌与激素382-44-5
    TargetMol 4-雄烯-11β-醇-3,17-二酮 11-Beta-hydroxyandrostenedio... 现货

     3720.00
    T14001 98.96%
    内分泌与激素1032823-75-8

    CAS号:1032823-75-8

    品名:gsk1292263;5-[[[1-(3-异丙基-1,2,4-噁二唑-5-基)-4-哌啶基]甲基]氧基]-2-[4-(甲磺酰基)苯基]吡啶5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole

    中文别名:gsk1292263;5-[[[1-(3-异丙基-1,2,4-噁二唑-5-基)-4-哌啶基]甲基]氧基]-2-[4-(甲磺酰基)苯基]吡啶

    英文别名:5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole

    分子式:C23H28N4O4S

    分子量:456.558

    精确质量:456.183

    Psa:106.8

    UNII号:R1J57STA6O

    密度:1.2±0.1g/cm3

    沸点:655.1±65.0°Cat760mmHg

    闪点:350.0±34.3°C

    折射率:1.565

    储存条件:-20℃

    蒸汽压:0.0±2.0mmHgat25°C

     1032823-75-8 详细信息

    内分泌与激素

    CAS号:1032823-75-8

    品名:gsk1292263;5-[[[1-(3-异丙基-1,2,4-噁二唑-5-基)-4-哌啶基]甲基]氧基]-2-[4-(甲磺酰基)苯基]吡啶5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole

    中文别名:gsk1292263;5-[[[1-(3-异丙基-1,2,4-噁二唑-5-基)-4-哌啶基]甲基]氧基]-2-[4-(甲磺酰基)苯基]吡啶

    英文别名:5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole

    分子式:C23H28N4O4S

    分子量:456.558

    精确质量:456.183

    Psa:106.8

    UNII号:R1J57STA6O

    密度:1.2±0.1g/cm3

    沸点:655.1±65.0°Cat760mmHg

    闪点:350.0±34.3°C

    折射率:1.565

    储存条件:-20℃

    蒸汽压:0.0±2.0mmHgat25°C

    展开

    内分泌与激素1032823-75-8
    阿拉丁 GSK1292263 GSK1292263 现货

     3058.90
    G127614 ≥98%
    内分泌与激素533884-09-2

    CAS号:533884-09-2

    品名:Erteberel(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol

    中文别名:Erteberel

    英文别名:2i0g;I0G;2i0j;Erteberel;

    分子式:C18H18O3

    分子量:282.334

    精确质量:282.126

    Psa:49.69

    UNII号:2ZUL6758TZ

    密度:

     533884-09-2 详细信息

    内分泌与激素

    CAS号:533884-09-2

    品名:Erteberel(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol

    中文别名:Erteberel

    英文别名:2i0g;I0G;2i0j;Erteberel;

    分子式:C18H18O3

    分子量:282.334

    精确质量:282.126

    Psa:49.69

    UNII号:2ZUL6758TZ

    密度:

    展开

    内分泌与激素533884-09-2
    TargetMol 化合物Erteberel Erteberel 现货

     4890.00
    T6306 99.87%
    内分泌与激素129453-61-8

    CAS号:129453-61-8

    品名:氟维司群Fulvestrant

    中文别名:氟维司琼;(7a,17b)-7-[9-(4,4,5,5,5-五氟戊亚磺酰基)壬烷基]-雌甾-1,3,5-(10)-三烯-3,17-二醇;

    英文别名:ICI182780;ICI-182,780;(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;Faslodex(TradeName);

    分子式:C32H47F5O3S

    分子量:606.771

    精确质量:606.317

    Psa:76.74

    RTECS号:KG7623000

    MDL号:MFCD00903953

    外观与性状:白色粉末

    密度:1.201 g/cm3

    沸点:674.8ºC at 760 mmHg

    闪点:361.9ºC

    折射率:1.521

    储存条件:2-8ºC

    蒸汽压:3.95E-19mmHg at 25°C

    海关编码:2930909090

    简介:Fulvestrant(tradenameFaslodex,byAstraZeneca)isadrugtreatmentofhormonereceptor-positivemetastaticbreastcancerinpostmenopausalwomenwithdiseaseprogressionfollowinganti-estrogentherapy.Itisacompleteestrogenreceptorantagonistwithnoagonisteffects,whichinaddition,acceleratestheproteasomaldegradationoftheestrogenreceptor.Thedrughaspoororalbioavailability,andisadministeredmonthlyviaintramuscularinjection.

    用途:是一类新的ER抑制剂ER下调剂类乳腺癌治疗药物。可与ER竞争性结合,其亲和力可与雌二醇相比。还可阻断ER,抑制其与雌激素的结合,并激发受体发生形态改变,降低ER浓度,从而使肿瘤细胞受到损害。用于治疗晚期已经发生全身转移的乳腺癌,用于抗雌激素疗法治疗无效、雌激素受体(ER)呈阳性的绝经后转移性晚期乳腺癌治疗。

     129453-61-8 详细信息

    内分泌与激素

    CAS号:129453-61-8

    品名:氟维司群Fulvestrant

    中文别名:氟维司琼;(7a,17b)-7-[9-(4,4,5,5,5-五氟戊亚磺酰基)壬烷基]-雌甾-1,3,5-(10)-三烯-3,17-二醇;

    英文别名:ICI182780;ICI-182,780;(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;Faslodex(TradeName);

    分子式:C32H47F5O3S

    分子量:606.771

    精确质量:606.317

    Psa:76.74

    RTECS号:KG7623000

    MDL号:MFCD00903953

    外观与性状:白色粉末

    密度:1.201 g/cm3

    沸点:674.8ºC at 760 mmHg

    闪点:361.9ºC

    折射率:1.521

    储存条件:2-8ºC

    蒸汽压:3.95E-19mmHg at 25°C

    海关编码:2930909090

    简介:Fulvestrant(tradenameFaslodex,byAstraZeneca)isadrugtreatmentofhormonereceptor-positivemetastaticbreastcancerinpostmenopausalwomenwithdiseaseprogressionfollowinganti-estrogentherapy.Itisacompleteestrogenreceptorantagonistwithnoagonisteffects,whichinaddition,acceleratestheproteasomaldegradationoftheestrogenreceptor.Thedrughaspoororalbioavailability,andisadministeredmonthlyviaintramuscularinjection.

    用途:是一类新的ER抑制剂ER下调剂类乳腺癌治疗药物。可与ER竞争性结合,其亲和力可与雌二醇相比。还可阻断ER,抑制其与雌激素的结合,并激发受体发生形态改变,降低ER浓度,从而使肿瘤细胞受到损害。用于治疗晚期已经发生全身转移的乳腺癌,用于抗雌激素疗法治疗无效、雌激素受体(ER)呈阳性的绝经后转移性晚期乳腺癌治疗。

    展开

    内分泌与激素129453-61-8
    TRC 氟维司群 Fulvestrant 期货,请咨询

     3949.00
    F862500 >95%
    内分泌与激素130663-39-7

    CAS号:130663-39-7

    品名:PD123319PD123319

    中文别名:PD123319

    英文别名:1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli;(6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylicacid;S-(+)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazol(4,5-c)pyridine-6-carboxylicacid;pd123,319di(trifluoroacetate)salt;PD123,319;(3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLICACID;(S)-1-&<&<4-(dimethylamino)-3-methylphenyl&>methyl&>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo&<4,5-c&>pyridine-6-carboxylicacid;PD123,319DITRIFLUOROACETATE;

    分子式:C31H32N4O3

    分子量:508.611

    精确质量:508.247

    Psa:78.67

    密度:1.22 g/cm3

    沸点:775.8ºC at 760 mmHg

    闪点:423ºC

    储存条件:2-8ºC

    蒸汽压:2.48E-25mmHg at 25°C

    危险品标志:Xi

     130663-39-7 详细信息

    内分泌与激素

    CAS号:130663-39-7

    品名:PD123319PD123319

    中文别名:PD123319

    英文别名:1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli;(6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylicacid;S-(+)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazol(4,5-c)pyridine-6-carboxylicacid;pd123,319di(trifluoroacetate)salt;PD123,319;(3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLICACID;(S)-1-&<&<4-(dimethylamino)-3-methylphenyl&>methyl&>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo&<4,5-c&>pyridine-6-carboxylicacid;PD123,319DITRIFLUOROACETATE;

    分子式:C31H32N4O3

    分子量:508.611

    精确质量:508.247

    Psa:78.67

    密度:1.22 g/cm3

    沸点:775.8ºC at 760 mmHg

    闪点:423ºC

    储存条件:2-8ºC

    蒸汽压:2.48E-25mmHg at 25°C

    危险品标志:Xi

    展开

    内分泌与激素130663-39-7
    阿拉丁 PD123319 PD123319 现货

     3398.90
    P129377 Moligand™,≥98%
    内分泌与激素1374598-80-7

    CAS号:1374598-80-7

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲基磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸半水合物2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid,hydrate

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲基磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸半水合物

    英文别名:(3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)aceticacidhemihydrate;(3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)aceticacidhydrate;UNII-8LDT91CH8A;Fasiglifamhemihydrate;3-Benzofuranaceticacid,6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)(1,1'-biphenyl)-3-yl)methoxy)-2,3-dihydro-,hydrate(2:1),(3S);

    分子式:C58H66O15S2

    分子量:1067.27

    精确质量:1066.38

    Psa:224.25

    UNII号:8LDT91CH8A

    密度:

    储存条件:-20℃

     1374598-80-7 详细信息

    内分泌与激素

    CAS号:1374598-80-7

    品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲基磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸半水合物2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid,hydrate

    中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲基磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸半水合物

    英文别名:(3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)aceticacidhemihydrate;(3S)-6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)biphenyl-3-yl)methoxy)-2,3-dihydro-l-benzofuran-3-yl)aceticacidhydrate;UNII-8LDT91CH8A;Fasiglifamhemihydrate;3-Benzofuranaceticacid,6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)(1,1'-biphenyl)-3-yl)methoxy)-2,3-dihydro-,hydrate(2:1),(3S);

    分子式:C58H66O15S2

    分子量:1067.27

    精确质量:1066.38

    Psa:224.25

    UNII号:8LDT91CH8A

    密度:

    储存条件:-20℃

    展开

    内分泌与激素1374598-80-7
    阿拉丁 TAK-875半水合物 TAK-875Hemihydrate 现货

     3706.90
    T129484 ≥99%
    内分泌与激素147403-03-0

    CAS号:147403-03-0

    品名:阿齐沙坦Azilsartan

    中文别名:2-乙氧基-1-[[2'-(4,5-二氢-5-氧代-1,2,4-恶二唑-3-基)联苯-4-基]甲基]苯并咪唑-7-羧酸;

    英文别名:2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylicacid;1H-Benzimidazole-7-carboxylicacid,1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy;TAK536;

    分子式:C25H20N4O5

    分子量:456.45

    精确质量:456.143

    Psa:123.24

    MDL号:MFCD20278186

    密度:1.42

    简介:AzilsartanisananalgesicandantiinflammatorydrugscontainingangiotensinIIantagonists.

    用途:阿齐沙坦是一款正处于研发中的治疗高血压症的血管紧张素II受体拮抗剂药物,多用于治疗高血压症,也是目前唯一处于末期临床的血管紧张素II受体拮抗剂(沙坦类)药物。

     147403-03-0 详细信息

    内分泌与激素

    CAS号:147403-03-0

    品名:阿齐沙坦Azilsartan

    中文别名:2-乙氧基-1-[[2'-(4,5-二氢-5-氧代-1,2,4-恶二唑-3-基)联苯-4-基]甲基]苯并咪唑-7-羧酸;

    英文别名:2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylicacid;1H-Benzimidazole-7-carboxylicacid,1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy;TAK536;

    分子式:C25H20N4O5

    分子量:456.45

    精确质量:456.143

    Psa:123.24

    MDL号:MFCD20278186

    密度:1.42

    简介:AzilsartanisananalgesicandantiinflammatorydrugscontainingangiotensinIIantagonists.

    用途:阿齐沙坦是一款正处于研发中的治疗高血压症的血管紧张素II受体拮抗剂药物,多用于治疗高血压症,也是目前唯一处于末期临床的血管紧张素II受体拮抗剂(沙坦类)药物。

    展开

    内分泌与激素147403-03-0
    TargetMol 阿齐沙坦 Azilsartan 现货

     3130.00
    T1057 99.87%
温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算
微信 ×

打开微信,点击底部的“发现”

使用“扫一扫”即可将网页分享至朋友圈